Our History

25 Years and Beyond

 

Our History

1991

  • Founded as Morwell Diagnostics GmbH in Zurich, Switzerland, provider of clinical diagnostic products.

1993

  • Establishment of manufacturing facilities for clinical products. Representation and distribution in over 75 countries.

1998

  • Establishment of MD Doctors Direct GmbH for the sale of point of care products into the clinic.

  • Formal distinction and formation of MD Biosciences for the manufacturing and sale of monoclonal research products and assays. Establishment of monoclonal production facility in Scotland for the production of ArthritoMab®

1999

  • Establishment of contract research operations focused on joint inflammation

2004

  • Expansion of contract research facilities with the establishment of in vivo facilities focused on all inflammatory diseases. Establishment of US based biomarker and assay development laboratories.

2006

  • Establishment of new laboratory focused on neurodegenerative diseases and pain

2008

  • Release of novel porcine translational models

2013

  • Release of Senerga ® Phenotypic Screening Platform and formation of the first screening program with Jannsen Research

2014

  • Expansion of US based in vivo operations to provide onco-immunology and metabolic disease focus

2015

  • Establishment of CLIA accredited clinical analysis laboratory in the US

  • Separation of histology and immunohistochemistry laboratory operations as a business unit in conjunction with diagnostic operations

  • Expansion of investment and risk-sharing program for the development of compounds of interest

2016

  • Research and development for MD 354 (chronic pain), MD 22 (inflammation/pain), and MD401B (canine osteocarcinoma vaccine), panel of biomarkers for gastrointestinal cancer diagnostics                      

  • Release of collaborative investment program to co-invest in promising early stage drug development.

 

Contact Us: 1-888-876-3246